Dr. Hoffman works via AGADA to provide consulting with clinical trial design, outcome measures (clinical and biomarker), and regulatory writing.  Regulatory experience includes both FDA and EMA.  Documents produced include orphan drug applications, pre-IND, Phase 1-2 transition, CHMP guidance, and EMA PDCO PIP (paediatric investigation plan).